Pocenbrodib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pocenbrodib, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 [Phase 1, Phase 2]